Why the study?
Does in vitro treatment of red cells with potassium cyanate improve red cell survival in patients with artificial heart valves?
Does in vitro treatment of red cells with potassium cyanate improve red cell survival in patients with artificial heart valves?
In vitro treatment with potassium cyanate improves red cell survival in patients with artificial heart valves, which are associated with varying degrees of subclinical haemolysis depending on valve type.
Answers are grounded in this paper and cite their sources.
May extend red cell survival in prosthetic valve patients; hypothesis-generating and requires randomized outcome trials.
Red cell survival was studied with use of Chromium-51 isotope and standard haematologic tests of haemolysis. The study comprised 30 patients with normally functioning single artificial heart valves of various types. They were investigated on 2 or 3 occasions. Red cells labelled with Cr-51 were treated for 30 min with potassium cyanate (0.5 mg/100 ml) in 5% invertose or with only 5% invertose. The mean red cell survival without cyanate treatment was 25 (+/- 4.2) days. Following cyanate treatment this figure improved to 31 (+/-4.8) days. Low-grade chronic intravascular haemolysis was associated with all the valve types. Abnormal results were found in 67% and 62% of the tests in patients with ball-type valve (deBakey and Starr-Edwards, respectively). The figures for tilting disc values (Lillehei-Kaster and Björk-Shiley) were 51 and 45.5%, while Carpentier-Edwards bioprosthetic valves gave 15.5% abnormal test results. The findings thus suggested that ball valves are more haemolytic than tilting disc valves, which in turn are more haemolytic than tissue valves.
No takes yet. Share an insight, caveat, or question.
Roberts et al. (1984) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: